Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gracell Biotechnologies Inc. - American Depositary Shares (NQ:GRCL)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Gracell Biotechnologies Inc. - American Depositary Shares

< Previous 1 2 3 4 5 6 Next >
Gracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus Erythematosus
From Gracell Biotechnologies Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Gracell Biotechnologies Presents Updated Clinical Data from FasTCAR-T GC012F Demonstrating Deep and Durable Responses in Newly Diagnosed Multiple Myeloma at ASH 2023
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Week In Review: Tang Capital Offers $465 Million For LianBio Plus 80% Of Any Licenses/Divestments
LianBio received a $465 million buyout offer from Tang Capital Management. In addition, Tang also offered shareholders a contingent value right for 80% of net proceeds from any license or divestment of... 
Via Talk Markets
A Preview Of Gracell Biotechnologies's Earnings
 
Via Benzinga
The Latest Analyst Ratings for Gracell Biotechnologies
 
Via Benzinga
Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus Erythematosus
From Gracell Biotechnologies Inc.
Via GlobeNewswire
4 Analysts Have This to Say About Gracell Biotechnologies
 
Via Benzinga
Preview: Gracell Biotechnologies's Earnings
 
Via Benzinga
Bitfarms And Other Big Stocks Moving Lower On Friday
U.S. stocks traded mixed, with the Dow Jones gaining around 90 points on Friday. Shares of Bitfarms Ltd. (NASDAQ: BITF) shares fell sharply during Friday’s session after the company announced a C$60... 
Via Benzinga
Topics Stocks
Gracell Biotechnologies to Participate in Inaugural Cell Therapy for Autoimmune Disease Summit
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Gracell Biotechnologies Reports Third Quarter 2023 Unaudited Financial Results and Provides Corporate Update
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Gracell Biotechnologies Wins Overall Immunology Solution of the Year by BioTech Breakthrough Awards Program
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Earnings Scheduled For November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
Gracell Biotechnologies to Present Updated Results from BCMA/CD19 Dual-Targeting FasTCAR-T GC012F in Newly Diagnosed Multiple Myeloma at the 65ᵗʰ American Society of Hematology Annual Meeting & Exposition
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Gracell Biotechnologies to Participate in Four Upcoming Investor Conferences
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Gracell Biotechnologies to Present Data Highlighting Preclinical Efficacy of SMART CART™ Against Solid Tumors at Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Gracell Biotechnologies to Report Third Quarter 2023 Financials on Monday, November 13, 2023
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2023
 
Via Benzinga
Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq
While ANL's IPO dropped more than 25% on its first day, netting just under $60M, private placement made up the difference. Plus: Deals, financings, trials and approvals. 
Via Talk Markets
Topics Initial Public Offering
Gracell Biotechnologies Reports Updated Clinical Data for FasTCAR-T GC012F for High-Risk, Newly Diagnosed Multiple Myeloma, Demonstrating 100% Stringent Complete Response Rate
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Gracell Biotechnologies Doses First Patient in Phase 1b/2 Clinical Trial in U.S. Evaluating GC012F for Treatment of Relapsed/Refractory Multiple Myeloma
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Gracell Biotechnologies’ CEO Dr. William Cao Named to Prestigious PharmaVoice 100, Honoring Most Inspiring Life Science Leaders
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Gracell Biotechnologies Reports Second Quarter 2023 Unaudited Financial Results and Provides Corporate Update
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership
BeiGene and Bristol-Myers Squibb have formally completed the breakup of the BeiGene-Celgene partnership, returning 23.3 million ordinary BeiGene shares to BeiGene. Meanwhile, Gracell Biotechnologies... 
Via Talk Markets
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback